TAO KIM: Open Payments
NPI 1598974214 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 96 payments from 21 companies in 2025. Trend: 2023 $1,869 · 2024 $1,267 · 2025 $2,493
Food & beverage: $2,408Education: $85
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $366 |
| ABBVIE INC. | 10 | $319 |
| UCB, Inc. | 14 | $300 |
| Janssen Biotech, Inc. | 9 | $252 |
| Novartis Pharmaceuticals Corporation | 12 | $236 |
| GENZYME CORPORATION | 6 | $195 |
| Organon LLC | 6 | $189 |
| Regeneron Healthcare Solutions, Inc. | 4 | $117 |
| Galderma Laboratories, L.P. | 4 | $103 |
| Incyte Corporation | 4 | $86 |
Products named: Bimzelx, CIBINQO, DUPIXENT, TREMFYA, COSENTYX, VTAMA, BOTOX, SKYRIZI.
Industry payments across MD — which companies pay providers there.
